Apimeds Pharmaceuticals Files 8-K
Ticker: APUS · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1894525
| Field | Detail |
|---|---|
| Company | Apimeds Pharmaceuticals Us, INC. (APUS) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC filing, disclosure
TL;DR
Apimeds Pharmaceuticals filed a routine 8-K on July 16th, reporting events from July 15th.
AI Summary
Apimeds Pharmaceuticals US, Inc. filed an 8-K on July 16, 2025, reporting events as of July 15, 2025. The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company is incorporated in Delaware and its principal executive offices are located in Matawan, New Jersey.
Why It Matters
This 8-K filing indicates a routine update or disclosure from Apimeds Pharmaceuticals US, Inc. to the SEC, providing information to investors and the public.
Risk Assessment
Risk Level: low — This filing appears to be a standard current report with no immediately apparent significant financial or operational changes disclosed.
Key Players & Entities
- Apimeds Pharmaceuticals US, Inc. (company) — Registrant
- July 15, 2025 (date) — Earliest event reported
- July 16, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Matawan, New Jersey (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Apimeds Pharmaceuticals US, Inc.?
The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating a disclosure of events as of July 15, 2025.
When was this 8-K report filed with the SEC?
The report was filed on July 16, 2025.
What is the state of incorporation for Apimeds Pharmaceuticals US, Inc.?
The company is incorporated in Delaware.
Where are the principal executive offices of Apimeds Pharmaceuticals US, Inc. located?
The principal executive offices are located at 100 Matawan Rd, Suite 325, Matawan, New Jersey 07747.
What is the IRS Employer Identification Number (EIN) for Apimeds Pharmaceuticals US, Inc.?
The EIN for Apimeds Pharmaceuticals US, Inc. is 85-1099700.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Apimeds Pharmaceuticals US, Inc. (APUS).